Penicillin Active Pharmaceutical Ingredients Market

Penicillin refers to a class of antibiotics containing penicillin in the molecule, which can destroy the cell wall of bacteria and play a bactericidal role in the breeding period of bacterial cells. It is an antibiotic extracted from Penicillium. Penicillin belongs to ?-lactam antibiotics, and ?-lactam antibiotics include penicillin, cephalosporin, carbapenems, monocyclic, and cephalosporins. Penicillin is a very common antibacterial drug. However, an intradermal test must be performed before each use to prevent allergies.

Penicillin Active Pharmaceutical Ingredients Market focuses on Penicillin Active Pharmaceutical Ingredients.

Penicillin Active Pharmaceutical Ingredients Market contains market size and forecasts of Penicillin Active Pharmaceutical Ingredients in global, including the following market information:

Global Penicillin Active Pharmaceutical Ingredients Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Penicillin Active Pharmaceutical Ingredients Market Sales, 2017-2022, 2023-2028, (MT)

Global top five Penicillin Active Pharmaceutical Ingredients companies in 2021 (%)

The global Penicillin Active Pharmaceutical Ingredients market was valued at 1880.1 million in 2021 and is projected to reach US$ 1710.7 million by 2028, at a CAGR of -1.3% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Amoxicillin Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Penicillin Active Pharmaceutical Ingredients include Centrient Pharmaceuticals, Jiangxi Fushine Pharmaceutical, Kelun, Harbin Pharmaceutical Group, Changzhou RedSun, Jiangxi Huabang, LKPC, Huaxing Pharma and North China Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Penicillin Active Pharmaceutical Ingredients manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Penicillin Active Pharmaceutical Ingredients Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)

Global Penicillin Active Pharmaceutical Ingredients Market Segment Percentages, by Type, 2021 (%)

Amoxicillin

Piperacillin

Benzylpenicillin Sodium

Ampicillin

Other

Global Penicillin Active Pharmaceutical Ingredients Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)

Global Penicillin Active Pharmaceutical Ingredients Market Segment Percentages, by Application, 2021 (%)

For Oral

For Injection

Global Penicillin Active Pharmaceutical Ingredients Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)

Global Penicillin Active Pharmaceutical Ingredients Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Penicillin Active Pharmaceutical Ingredients revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Penicillin Active Pharmaceutical Ingredients revenues share in global market, 2021 (%)

Key companies Penicillin Active Pharmaceutical Ingredients sales in global market, 2017-2022 (Estimated), (MT)

Key companies Penicillin Active Pharmaceutical Ingredients sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Centrient Pharmaceuticals

Jiangxi Fushine Pharmaceutical

Kelun

Harbin Pharmaceutical Group

Changzhou RedSun

Jiangxi Huabang

LKPC

Huaxing Pharma

North China Pharmaceutical

Qilu Tianhe Pharma

Novartis (Sandoz Anti-Infectives)

CSPC Zhongrun

United Laboratories

Sinopharm Weiqida Pharmaceutical

Changsheng Pharma

Aurobindo Pharma

Novartis

ACS Dobfar